News


FSD Pharma Announces Launch of New Corporate Website

January 20th, 2022 - Ryan Allway

New Website Shares FSD’s Unique Drug Pipeline and Vision to Improve the Quality of Life for Patients Suffering from Brain & Inflammatory Disorders   TORONTO, January 20, 2022–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company“), a life sciences holding company dedicated to building a portfolio of assets and […]

Canntab Officially Launches Its Online E-commerce Platform

January 20th, 2022 - Ryan Allway

TORONTO, Jan. 20, 2022 /CNW/ – Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) (the “Company” or “Canntab”), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the official launch of its online e-commerce platform and web site at www.Canntab.ca.   The E-Commerce platform and web site provides Canadians with […]

Decibel Announces Stock Option Grants

January 20th, 2022 - Ryan Allway

CALGARY, AB, Jan. 20, 2022 /CNW/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSX-V: DB) (OTCQB: DBCCF), a premium cannabis producer, announces that it has granted, effective after market close on January 19, 2022, an aggregate of 3,471,294 stock options (each, an “Option”) to certain officers and employees of the Company in accordance with the Company’s stock […]

BioHarvest Sciences Inc. Plans to Build a Production Facility in Ontario to Serve the Canadian Market with Unique Cannabis Products

January 20th, 2022 - Ryan Allway

The Company is now producing Cannabis in industrial scale bioreactors and has entered the final stage of its Cannabis commercialization program Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – January 20, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has announced its plan to build a production facility in Canada, as part […]

Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results

January 20th, 2022 - Ryan Allway

Strong execution leads to third consecutive quarter of positive Adjusted EBITDA Company recorded quarterly revenues of $6.6 million Growing operations initiated at new Valleyfield Facility     All financial results are reported in Canadian dollars, unless otherwise stated. MONTREAL, January 20, 2022 /CNW Telbec/ – Cannara Biotech Inc. (“Cannara” or the “Company“) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically […]

CubicFarms Announces $1.26M HydroGreen Sales in North and South Dakota

January 20th, 2022 - Ryan Allway

HydroGreen Certified Dealer Grohs International Orders Nine Modules   VANCOUVER, British Columbia, January 20, 2021 – CubicFarm® Systems Corp. (“CubicFarms” or the “Company”) (TSX:CUB), a leading local chain agricultural technology company, today announced the sale of nine HydroGreen Grow System modules in North Dakota and South Dakota.   On October 25, 2021, HydroGreen Certified Dealer […]

Should You Use CBD to Help Your Puppy Sleep?

January 19th, 2022 - Ryan Allway

Cannabidiol, better known as CBD, has become one of the world’s most popular health and wellness supplements for pets. According to Grand View Market Research, nearly a quarter of pet owners consume CBD-based products for themselves or their pets. And CBD could help treat medical conditions, including pain, anxiety, and sleep disorders. Sleep is a […]

1933 Industries Announces Partnership Between Day One Beverages and USA Pickleball Association

January 19th, 2022 - Ryan Allway

Leading CBD Drinks Brand Aligns with USA’s Fastest Growing Sport, Keeping Players Refreshed and Revitalized VANCOUVER, BC / ACCESSWIRE / January 19, 2022 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis consumer packaged goods company, is pleased to announce that Day One Beverages, Inc. (“Day One”) has been named the exclusive […]

M2Bio Sciences (OTC: $WUHN) Launches Mental Illness Drug Discovery Company Neurai Life Sciences.

January 19th, 2022 - Ryan Allway

CAPE TOWN, SA / ACCESSWIRE / January 19, 2022 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update:   Wuhan General Group, Inc./M2Bio Sciences, Inc. is excited to announce the launch of Neurai Life Sciences.   […]

Martha Stewart CBD Launches its First-Ever Category Expansion with New Line of CBD Wellness Topicals

January 19th, 2022 - Ryan Allway

New Super Strength CBD Cream, Sleep Science CBD Cream and Daily De-Stress CBD Cream Add to Martha’s Wellness Portfolio   ­­SMITHS FALLS, ON and NEW YORK, Jan. 19, 2022 /PRNewswire/ – Today, Martha Stewart CBD unveiled Martha Stewart CBD Wellness Topicals, marking the brand’s first-ever category expansion in its growing CBD portfolio. Martha Stewart CBD provides consumers with […]

FIRE & FLOWER announces filing of form 40-F with sec as company prepares for nasdaq listing

January 19th, 2022 - Ryan Allway

TORONTO, Jan. 19, 2022 /CNW/ – Fire & Flower Holdings Corp. (“Fire & Flower” or the “Company“) (TSX: FAF) (OTCQX: FFLWF), a leading, technology-powered, cannabis retailer, today announced the filing of its Form 40-F Registration Statement (“Form 40-F“) with the United States Securities and Exchange Commission (the “SEC“), in preparation for the Company to list its shares on The […]

Tinley’s Long Beach Facility to Produce ‘Green Monké’ Sodas on Can Line; Tinley’s Closes First Tranche of Non-Brokered Private Placement

January 19th, 2022 - Ryan Allway

TORONTO and LOS ANGELES, Jan. 19, 2022 (GLOBE NEWSWIRE) — The Tinley Beverage Company Inc. (CSE:TNY; OTC:TNYBF) (“Tinley’s” or the “Company”) is pleased to announce that international cannabis beverage brand ‘Green Monké’ is scheduled to begin can line production of five planned flavours at Tinley’s Long Beach Facility in Q1 2022, with production of full-batches […]

Allied Corp Signs Supply Agreement for 1000KGS Monthly and Completes Manufacturing Process for Allied Inside(TM) Veteran Focused CBD Cigarette

January 19th, 2022 - Ryan Allway

KELOWNA, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is pleased to announce the signing of a dual-purpose agreement with Porter Ventures, LLC that is based in the United States. All products involved with this working relationship are below the 0.3% THC limit and are legal to be sold […]

Silver Spike Investment Corp. Announces Proposed Initial Public Offering

January 18th, 2022 - Ryan Allway

NEW YORK, January 18, 2022–(BUSINESS WIRE)–Silver Spike Investment Corp. (“SSIC”), a newly-organized closed-end management investment company that has elected to be treated as a business development company, plans to make an initial public offering of 8,928,572 shares of its common stock. The price for the offering is $14.00 per share of common stock. SSIC is […]

Update: Hemp, Inc. Announces Launch of CBDA and CBGA Products in Response to New Covid Study Findings

January 18th, 2022 - Ryan Allway

Las Vegas, NV, Jan. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — From old-fashioned to new-fashioned, hemp has done it again and Hemp, Inc. (OTC PINK: HEMP) is right on the forefront. The Company announced it will be launching a CBDA and CBGA line of water, tinctures, gummies, capsules, and edibles, as its primary cannabinoids. With 14 […]

Heritage Cannabis Announces Affiliate Endocanna Enters Strategic Partnership With OMNI Medical Services

January 18th, 2022 - Ryan Allway

TORONTO, January 18, 2022–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that Endocanna Health (“Endocanna”), a company in which Heritage holds a 30% non-controlling interest, has entered into a strategic partnership with OMNI Medical Services (“OMNI”). OMNI is a multi-state operator of medical cannabis clinics, evaluations, research, pain […]

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

January 18th, 2022 - Ryan Allway

701 subjects dosed to date Initiating enrollment activities in Turkey as part of its clinical diversification plans to support global regulatory approvals On-track to complete enrollment in Q1-2022 and FDA submission thereafter Commencing regulatory package activities for submission to international regulatory authorities for drug approvals   TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) — Revive Therapeutics […]

urban-gro, Inc. Announces Increase to Its Stock Repurchase Program

January 18th, 2022 - Ryan Allway

LAFAYETTE, Colo., Jan. 18, 2022 (GLOBE NEWSWIRE) — urban-gro, Inc. (Nasdaq: UGRO) (“urban-gro” or the “Company”), a fully integrated architectural, engineering and cultivation systems integration company focused on the indoor Controlled Environment Agriculture (“CEA”) market, today announced that its Board of Directors has authorized an increase of $2 million to the Company’s existing stock repurchase program. Under […]

Xebra Granted Trademarks in the European Union

January 18th, 2022 - Ryan Allway

VANCOUVER, BC, Jan. 18, 2022 /PRNewswire/ – Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC), a cannabis company, is pleased to announce that it has been granted trademarks in the European Union, covering 28 countries and 10 territories, for Xebra’s THC and CBD infused beverage brands, including MADCAP soft drinks, and the slogan Crazy Good, HOLAHI iced teas and the slogan It’s High […]

Eden Empire Announces Issuance of License for Dispensary in British Columbia

January 18th, 2022 - Ryan Allway

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “Eden Empire”) is pleased to announce that it has received its Cannabis Retail Store License Authorization (the “License”) from the Liquor & Cannabis Regulation Branch (the “LCRB”) for its cannabis dispensary location at 30 Lakeshore Dr. NW in […]

SciSparc Advances Its Phase IIb Clinical Trial in Patients with Tourette Syndrome with its Proprietary Drug Candidate SCI-110

January 18th, 2022 - Ryan Allway

The Dual-Site Study Will Be Conducted at the Hannover Medical School in Germany, and Israel’s Tel-Aviv Sourasky Medical Center   TEL AVIV, Israel, Jan. 18, 2022 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today announced […]

Item 9 Labs Corp. Reports Record FY 2021 Annual Financial Results with Revenue Growth of 170% to $21.9 Million Revenue

January 18th, 2022 - Ryan Allway

– Cultivation, Production and Processing Expansion Ongoing in Arizona and Nevada – Unity Rd. Brand Accelerates Ramp by Signing Ten Agreements for National Cannabis Dispensary Franchise Expansion – Management to Host Conference Call and Webcast to Discuss Key Operational and Financial Highlights Today at 2:00 p.m. ET     PHOENIX, Jan. 18, 2022 /PRNewswire/ — Item 9 Labs […]

Lakewood issued Distribution License at Tinley’s Long Beach Facility; Tinley’s Brand Product Clears State Testing Onsite; Client Batches Set to Follow This Month

January 18th, 2022 - Ryan Allway

TORONTO and LOS ANGELES, Jan. 18, 2022 (GLOBE NEWSWIRE) — The Tinley Beverage Company Inc. (CSE:TNY; OTC:TNYBF) (“Tinley’s” or the “Company”) is pleased to announce that, for the first time, a batch of product manufactured at Tinley’s Long Beach Facility has successfully completed the State of California’s testing, quarantine and lab sampling processes onsite under […]

FSD Pharma Congratulates Dr. Eleanor Fish on Being Named to the Order of Canada

January 18th, 2022 - Ryan Allway

TORONTO, January 18, 2022–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, warmly congratulates Eleanor N. Fish, Ph.D., a member of its Research and Clinical Advisory Board, on her appointment to the Order of […]

Psyched Wellness Announces Vantage Hemp Co. as Contract Manufacturing Organization Partner to Bring AME-1-derived Products to Market

January 18th, 2022 - Ryan Allway

Canadian brand leading the emerging functional food category partners with industry-leading extraction and manufacturing partner based in Greeley, Colorado   Toronto, Ontario–(Newsfile Corp. – January 18, 2022) – Psyched Wellness Ltd., (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, […]

MariMed To Acquire Illinois Craft Cannabis License Allowing for Vertically Integrated Cannabis Operations

January 18th, 2022 - Ryan Allway

NORWOOD, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) — MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it signed a definitive agreement to acquire Green Growth Group, Inc. (“Green Growth”), holder of a provisional Cannabis Craft License in Illinois. The transaction is subject […]

Red White & Bloom Receives Full Licensing, Commences Operation of 15,000 Sq. Ft. Michigan Cannabis Manufacturing/Processing Facility

January 18th, 2022 - Ryan Allway

Warren facility to become RWB’s central cannabis manufacturing, processing and distribution hub in Michigan, enabling distribution of RWB products to Michigan’s 400+ dispensaries — a $1.8 billion market where Platinum Vape™ was named a Biggest Brand by LeafLink and the #1 brand vape in Michigan by ArcView. 15,000 sq. ft. fully built-out facility, with the […]

Canonic Announces Positive Results in Pre-Clinical Studies in its Precise Product Program for Medical Cannabis T

January 18th, 2022 - Ryan Allway

The results support the successful identification of specific cannabis varieties with anti-inflammatory and pain relief properties, for which Canonic recently filed a patent application REHOVOT, Israel, Jan. 18, 2022 /PRNewswire/ — Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today positive results in pre-clinical […]

Yooma Wellness Announces Launch of MYO Plant Nutrition in Boots Stores Across the UK

January 17th, 2022 - Ryan Allway

Products will be available in up to 838 stores across the UK Toronto, Ontario, Canada, Jan. 17, 2022 (GLOBE NEWSWIRE) — Yooma Wellness Inc. (“Yooma“) (CSE: YOOM, AQSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce that Boots, one of the […]

West Island to Begin Sales in Quebec

January 17th, 2022 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – January 17, 2022) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) (“West Island” or the “Company”) is pleased to announce that the Company’s subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture (“West Island”) has signed a Letter of Intent (the “LOI”) with the Société Québécoise Du Cannabis (the “SQDC”). […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading